{{Rsnum
|rsid=2208532
|Gene=SRD5A2
|Chromosome=2
|position=31563919
|Orientation=plus
|GMAF=0.4229
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SRD5A2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 37.5 | 46.4 | 16.1
| HCB | 21.2 | 44.5 | 34.3
| JPT | 26.5 | 55.8 | 17.7
| YRI | 46.3 | 42.9 | 10.9
| ASW | 43.9 | 42.1 | 14.0
| CHB | 21.2 | 44.5 | 34.3
| CHD | 22.9 | 49.5 | 27.5
| GIH | 18.8 | 56.4 | 24.8
| LWK | 51.8 | 44.5 | 3.6
| MEX | 25.9 | 43.1 | 31.0
| MKK | 37.2 | 48.7 | 14.1
| TSI | 27.5 | 52.9 | 19.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=19574343
|Title=Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3)
|OA=1
}}

{{PMID Auto
|PMID=21715084
|Title=SRD5A Polymorphisms and Biochemical Failure After Radical Prostatectomy
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}